The SARS-CoV-2/Influenza A+B/RSV Antigen Combo Rapid Test is intended for use by trained clinical laboratory personnel. An inhaler (bronchodilator) or steroids are not proved to be helpful in treating RSV infection. A breathing machine (mechanical ventilation), in rare cases. Treatments at the hospital may include: Intravenous (IV) fluids. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with SARS-CoV-2, Influenza A+B and RSV. If the RSV infection is severe, a hospital stay may be necessary. Negative results should be treated as presumptive and confirmed with a molecular assay, if necessary for patient management. These tests may use direct or indirect fluorescent immunoassay, immunochromatographic, or lateral flow techniques to produce rapid and accurate results, typically in less than 30 minutes. This test detects the presence or absence of SARS-CoV-2, the virus that causes COVID-19, as well as influenza A or B, and Respiratory Syncytial Virus (RSV). Negative results do not preclude SARS-CoV-2/Influenza A+B/RSV infection and should not be used as the sole basis for treatment or patient management decisions. Antigen assays typically detect nucleocapsid proteins from a virus like SARS-CoV-2 or Flu A+B. The Pixel by Labcorp® COVID-19 + Flu + RSV at-home kit is a PCR test, also known as a reverse polymerase chain reaction test or a nucleic acid amplification test (NAAT). The agent detected may not be the definite cause of disease. Positive results do not rule out other bacterial/viral infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. An antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Results are for the detection of SARS-CoV-2, Influenza A+B and RSV Antigens. Rarely, rapid tests may provide a false positive result. The SARS-CoV-2/Influenza A+B/RSV Antigen Combo Rapid Test (Nasopharyngeal Swab) is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2, Influenza A, Influenza B and Respiratory Syncytial Virus(RSV) antigens in nasopharyngeal swab specimens from individuals with suspected SARS-CoV-2/Influenza/RSV infection in conjunction with clinical presentation and the results of other laboratory tests. Rapid SARS-CoV-2 Antigen Test Card, 1 Pack, 8 Tests Total, FDA EUA Authorized OTC at-Home Self Test, Results in 15 Minutes, Convenient and Comfortable to use. A rapid or at-home COVID-19 test is a quick and convenient way to find out if a person has COVID-19.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |